0001053310-12-000001.txt : 20120629
0001053310-12-000001.hdr.sgml : 20120629
20120629183237
ACCESSION NUMBER: 0001053310-12-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120627
FILED AS OF DATE: 20120629
DATE AS OF CHANGE: 20120629
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KAY E GERALD
CENTRAL INDEX KEY: 0001053310
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-31668
FILM NUMBER: 12937066
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTEGRATED BIOPHARMA INC
CENTRAL INDEX KEY: 0001016504
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222407475
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 201 ROUTE 22
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
BUSINESS PHONE: 9739260816
MAIL ADDRESS:
STREET 1: 201 ROUTE 22
CITY: HILLSIDE
STATE: NJ
ZIP: 07205
FORMER COMPANY:
FORMER CONFORMED NAME: INTEGRATED HEALTH TECHNOLOGIES INC
DATE OF NAME CHANGE: 20020912
FORMER COMPANY:
FORMER CONFORMED NAME: CHEM INTERNATIONAL INC
DATE OF NAME CHANGE: 19960716
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0305
4
2012-06-27
0
0001016504
INTEGRATED BIOPHARMA INC
INBP.OB
0001053310
KAY E GERALD
225 LONG AVENUE
HILLSIDE
NJ
07205
1
1
1
0
CEO AND PRESIDENT
COMMON STOCK
2012-06-27
4
S
0
250000
0.09
D
5270444
D
Shares disposed of in connection with a refinancing transaction involving the issuer. The Reporting Person has no preset intent to dispose of additional shares.
Includes (i) 819,629 shares of common stock held by EGK LLC, of which the Reporting Person is the manager; and (ii) 307,888 shares of common stock issuable upon exercise of presently exercisable stock options; the Reporting Person shares dispositive power with Christina Kay with respect to 169,358 shares of common stock and with Riva Sheppard with respect to 169,358 shares of common stock.
/S/ E. GERALD KAY
2012-06-29